Alpine Immune Sciences Inc
ALPN
ALPN was delisted on the 17th of May, 2024.
35 hedge funds and large institutions have $110M invested in Alpine Immune Sciences Inc in 2020 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 4 closing their positions.
325% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 4
233% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 3
60% more capital invested
Capital invested by funds: $69.2M → $110M (+$41.2M)
59% more funds holding
Funds holding: 22 → 35 (+13)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
+$11.7M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$7.41M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
+$6.78M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$6.78M |
| 5 |
AG
Artal Group
Luxembourg
|
+$5.42M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCA
Berman Capital Advisors
Atlanta,
Georgia
|
-$529K |
| 2 |
HP
Hikari Power
Tokyo,
Japan
|
-$366K |
| 3 |
PFO
Pathstone Family Office
Englewood,
New Jersey
|
-$97K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$75.4K |
| 5 |
Morgan Stanley
New York
|
-$15.2K |
ALPN Hedge Fund Activity: Q3 2020 in Review
35 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q3 2020, worth a combined $110M — up 60% from $69.2M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new ALPN positions and 4 closed out — a net gain of 13 holders — while 10 added to existing stakes and 3 trimmed.
The largest buyer was Omega Fund Management, opening a new position worth an estimated $11.7M. The largest seller was Berman Capital Advisors, exiting entirely with an estimated $529K sold.
- 35 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q3 2020, up from 22 in Q2 2020.
- Funds reported $110M of Alpine Immune Sciences Inc stock for Q3 2020, up 60% quarter-over-quarter.
- 17 funds opened new Alpine Immune Sciences Inc positions in Q3 2020 and 4 closed out, a net change of +13 holders.
- The largest Alpine Immune Sciences Inc buyer in Q3 2020 was Omega Fund Management, an estimated $11.7M added.
- The largest Alpine Immune Sciences Inc seller in Q3 2020 was Berman Capital Advisors, an estimated $529K sold.
Based on aggregated 13F filings for Q3 2020.